# Impact of Local Lidocaine Paravertebral Cervical Injection on Cervicogenic Dizziness Symptoms

> **NCT07053176** · PHASE4 · ENROLLING_BY_INVITATION · sponsor: **Uniter Onlus** · enrollment: 42 (estimated)

## Conditions studied

- Cervicogenic Dizziness

## Interventions

- **DRUG:** 0.5% Lidocaine
- **DRUG:** Saline Solution (NaCl 0,9%)

## Key facts

- **NCT ID:** NCT07053176
- **Lead sponsor:** Uniter Onlus
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2025-08-01
- **Primary completion:** 2025-09-15
- **Final completion:** 2025-09-15
- **Target enrollment:** 42 (ESTIMATED)
- **Last updated:** 2025-07-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07053176

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07053176, "Impact of Local Lidocaine Paravertebral Cervical Injection on Cervicogenic Dizziness Symptoms". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT07053176. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*